Literature DB >> 15240867

Oxygen tension and inhaled nitric oxide modulate pulmonary levels of S-nitrosocysteine and 3-nitrotyrosine in rats.

Scott A Lorch1, David Munson, Richard T Lightfoot, Harry Ischiropoulos.   

Abstract

The oxidative environment within the lung generated upon administration of oxygen may be a critical regulator for the efficacy of inhaled nitric oxide therapy, possibly as a consequence of changes in nitrosative and nitrative chemistry. Changes in S-nitrosocysteine and 3-nitrotyrosine adducts were therefore evaluated after exposure of rats to 80% or >95% oxygen for 24 or 48 h with and without 20 ppm inhaled nitric oxide. Exposure to 80% oxygen led to increased formation of S-nitrosocysteine and 3-nitrotyrosine adducts in lung tissue that were also associated with increased expression of iNOS. The addition of inhaled nitric oxide in 80% oxygen exposure did not alter any of these adducts in the lung or in the bronchoalveolar lavage (BAL). Exposure to >95% oxygen led to a significant decrease in S-nitrosocysteine and an increase in 3-nitrotyrosine adducts in the lung. Co-administration of inhaled nitric oxide with >95% oxygen prevented the decrease in S-nitrosocysteine levels. The levels of S-nitrosocysteine and 3-nitrotyrosine returned to baseline in a time-dependent fashion after termination of exposure to >95% oxygen and inhaled nitric oxide. These data suggest the formation of S-nitrosating and tyrosine-nitrating species is regulated by oxygen tensions and co-administration of inhaled nitric oxide restores the nitrosative chemistry without a significant impact upon the nitrative pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240867     DOI: 10.1203/01.PDR.0000134256.30519.9B

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death.

Authors:  Viktoria Vereczki; Erica Martin; Robert E Rosenthal; Patrick R Hof; Gloria E Hoffman; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2006-06       Impact factor: 6.200

2.  Nitric oxide counteracts the hyperoxia-induced proliferation and proinflammatory responses of mouse astrocytes.

Authors:  Christie J Bruno; Todd M Greco; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

3.  Inhaled nitric oxide prevents 3-nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.

Authors:  Michael R Stenger; Melissa J Rose; Mandar S Joshi; Lynette K Rogers; Louis G Chicoine; John Anthony Bauer; Leif D Nelin
Journal:  Lung       Date:  2010-03-17       Impact factor: 2.584

4.  Opposing regulation of human alveolar type II cell differentiation by nitric oxide and hyperoxia.

Authors:  Lindsay C Johnston; Linda W Gonzales; Richard T Lightfoot; Susan H Guttentag; Harry Ischiropoulos
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

Review 5.  Comparative Response of Brain to Chronic Hypoxia and Hyperoxia.

Authors:  Laura Terraneo; Michele Samaja
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.